An outstanding opportunity exists with a leading pharmaceutical provider of prescription medicine treatments in Australia and throughout the world. They combine global experience with local knowledge and understanding to deliver pharmaceutical products that make a significant difference to patient outcomes.

In your new organisation, you will play a significant role – and your effort will be recognised! This is a great opportunity to achieve your potential. Our client is looking for a GP sales representative, based in the south western suburbs of Melbourne to maximise sales volumes and market share of designated products.

You will preferably have a science degree and you will be a current GP Rep, with a track record of sales success and achievements. You will be challenged by achieving sales targets and increasing market share for your assigned territory, as well as providing input to the overall performance of VIC.

In return, you will enjoy enormous support and training and be backed by a global, multi-national organisation who will reward your efforts and experience.

To explore this opportunity further, send your resume by “applying now” or contacting Aliza Segal at pharMED Talent on 02.9817.0599.

Disclaimer:

The Australian Medicines Industry takes no responsibility for the content of the job recruitment advertisements as they have been posted by independent recruiters.

Amgen Australia, Baxter Healthcare, GlaxoSmithKline Australia and Merck Serono Australia were among 125 organisations nationally to be cited as organisations that are recognising and advancing women in the workplace.

The initiative is run by the Federal Government’s Equal Opportunity for Women in the Workplace Agency to acknowledge organisations that recognise and advance women in the workplace.

I think the fact that four members of the Australian medicines industry were awarded with such a citation reflects the industry’s track record in promoting equal opportunity for women in the workplace.

These citations point to an industry that has works hard at fostering gender equity and has a demonstrated commitment to equal opportunity for women.

They point to an industry culture that is inclusive, and send a clear message that the Australian medicines industry is a great place to work.

So we are not just a manufacturing industry that is innovative, high skill, high wage, low-carbon and a leading exporter. The Australian medicines industry can also show its credentials as an equal opportunity employer where both men and women can enjoy working in skilled, high wage jobs.

An outstanding opportunity exists with a leading pharmaceutical provider of prescription medicine treatments in Australia and throughout the world. They combine global experience with local knowledge and understanding to deliver pharmaceutical products that make a significant difference to patient outcomes.

In your new organisation you will play a significant role – and your effort will be recognised! This is a great opportunity to achieve your potential.

Our client is looking for an Executive GP Sales Advisor for Sydney’s South Western suburbs to facilitate a better understanding of treatment gaps for chronically ill patients and to highlight how e-health systems will benefit patients.

This is an opportunity for an experienced GP sales rep to have in depth discussions with doctors and practice managers where your business acumen will maximise sales volumes and market share of designated products in two disease states.

You will preferably have a science or commercial degree and be a current GP rep with a track record of sales success and achievements or you may be a sales consultant in a medically allied area looking to go into pharma.  You will be challenged by achieving sales targets and increasing market share for your assigned territory, as well as providing input to the overall performance of NSW.

In return, you will enjoy enormous support and training and be backed by a global, multi-national organisation that will reward your efforts and experience.

To explore this opportunity further, send your resume by clicking on the apply link below or contacting Aliza Segal at pharMED Talent on 02.9817.0599.

Disclaimer:

The Australian Medicines Industry takes no responsibility for the content of the job recruitment advertisements as they have been posted by independent recruiters.

An outstanding opportunity exists with a leading pharmaceutical provider of prescription medicine treatments in Australia and throughout the world. They combine global experience with local knowledge and understanding to deliver pharmaceutical products that make a significant difference to patient outcomes.

In your new organisation you will play a significant role – and your effort will be recognised! This is a great opportunity to achieve your potential.

Our client is looking for an Executive GP Sales Advisor for Sydney’s South Western suburbs to facilitate a better understanding of treatment gaps for chronically ill patients and to highlight how e-health systems will benefit patients.

This is an opportunity for an experienced GP sales rep to have in depth discussions with doctors and practice managers where your business acumen will maximise sales volumes and market share of designated products in two disease states.

You will preferably have a science or commercial degree and be a current GP rep with a track record of sales success and achievements or you may be a sales consultant in a medically allied area looking to go into pharma.  You will be challenged by achieving sales targets and increasing market share for your assigned territory, as well as providing input to the overall performance of NSW.

In return, you will enjoy enormous support and training and be backed by a global, multi-national organisation that will reward your efforts and experience.

To explore this opportunity further, send your resume by clicking on the apply link below or contacting Aliza Segal at pharMED Talent on 02.9817.0599.

Disclaimer:

The Australian Medicines Industry takes no responsibility for the content of the job recruitment advertisements as they have been posted by independent recruiters.

Since its inception in 1833, ING has come a long way to become one of the leading providers of life insurance, superannuation, retirement incomes, financial planning and trustee services to around one million customers in Australia and New Zealand. Recently winning a ‘Risk Insurance Innovation Award’ at the Association of Financial Advisers (AFA) and ‘Plan for Life’s 2010 Life Company of the Year’ Awards, ING continues to be the reigning provider of life insurance to financial advisers in Australia and New Zealand. As a part of the Suncorp Group, ING is backed with years of experience, knowledge and clarity for a responsive approach towards their customers.

Choosing ING Insurance will boost your confidence to live the life you want to live. You can secure your family’s future by choosing from the following insurance coverage offered ING:

• lifeinsurance.org
• Trauma Insurance
• Total & Permanent Disablement (TPD)
• Life Insurance (Death Cover)
• Total & Permanent Disablement (TPD)
• Business Expenses Insurance

Another well-received insurance product by ING is the ‘ING Lifeguard’ which promises to provide real benefits to clients, their families and businesses. Having a First Choice super account with Colonial First State at ING will let you enjoy some important tax and cash flow benefits such as:

• Life Cover Super
• Life Cover and Total and Permanent Disability (TPD) Super
• Income Shield Super
• A premium-free Child Cover Option
• Cancer cover option

To know more on Asteron life insurance policies lifeinsurance.org and compare life insurance quotes for free. Life Insurance Direct is an online life insurance comparison website aimed at delivering its clients competitively yet comprehensive policies.

The Australian Medicines Industry made available no fewer than 21 brand new medicines to Australian patients through the Pharmaceutical Benefits Scheme. These include four new medicines to treat Type 2 diabetes, four for hypertension, three for rheumatoid arthritis and other treatments for prostate cancer, osteoporosis, migraines and infertility.

Once a new medicine is listed on the PBS, the full cost of the medicine is subsidised by the Government, so patients pay no more than $35.40 for each medicine.

The Australian Medicines Industry is working hard to bring as many new medicines to market via the PBS as quickly as possible, and in this regard I’d say 2010-11 was a good year. The bottom line is that health outcomes of thousands of Australian patients should improve as a result of these new medicines being developed.

The number of new medicines for 2010-11 compares well with the corresponding figure for the previous 12 months, when 12 new medicines were brought on to the PBS.

And globally, the number of new medicines under development grew by 100 in 2011 to 3050.

That has to be promising news for patients.